Justin Bowers
Stock Analyst at Deutsche Bank
(1.85)
# 3,254
Out of 5,132 analysts
40
Total ratings
37.5%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $375 → $315 | $319.83 | -1.51% | 4 | Aug 5, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $416.04 | +3.36% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $168.85 | +56.94% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $10.27 | +123.95% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $23.89 | +21.39% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $17.51 | +42.78% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $132.63 | +16.87% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $509.82 | +19.65% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $59.54 | +37.72% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $9.14 | +173.52% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.02 | +462.91% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $80.08 | +274.63% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $214.94 | +27.94% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $243.61 | +2.62% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $158.74 | +82.69% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.29 | +182.38% | 5 | May 10, 2021 |
Waters
Aug 5, 2025
Maintains: Hold
Price Target: $375 → $315
Current: $319.83
Upside: -1.51%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $416.04
Upside: +3.36%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $168.85
Upside: +56.94%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $10.27
Upside: +123.95%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $23.89
Upside: +21.39%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $17.51
Upside: +42.78%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $132.63
Upside: +16.87%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $509.82
Upside: +19.65%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $59.54
Upside: +37.72%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $9.14
Upside: +173.52%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.02
Upside: +462.91%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $80.08
Upside: +274.63%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $214.94
Upside: +27.94%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $243.61
Upside: +2.62%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $158.74
Upside: +82.69%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.29
Upside: +182.38%